The Scientist Best Places to Work
**Survey open September through November**

By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
Hannah Waters

Survey Rankings

See all the ranking results from this year’s survey. Review the strengths and weaknesses of the Top 40 companies in online tables. Also, breakdown the Top 10 small and Top 10 large companies by the numbers.

This year’s No. 1 company has grown exponentially since its founding in 2007, with a research focus on the epigenetics of cancer and developing drugs to modify variations in DNA methylation.

Ranked No. 8 among this year’s top companies, DNA Genotek has found a surprising new source of revenue—licensing its products to genetic-testing companies.

This year’s top large companies excel at maintaining communication among their far-reaching branches, sharing information across the globe to keep research running smoothly and efficiently.

Many of this year’s top companies are taking advantage of government-funded programs that provide specialized training and services, improving research productivity and employee morale.

Details about how we arrived at this year's results. The survey for BPTW:Industry opens in September and remains open through November.
Click Here

Survey Series
Year

 

How does your pay compare?

Find out how your salary stacks up against your colleagues', which fields and regions are paying best for life scientists, and more.

 

In bed with big pharma
Instead of striking traditional licensing deals with academic labs that produce commercializable results, companies are starting to reach farther back, all the way to the inception of basic research projects.

Finding New Money
In tough times, researchers have to look outside of government funding. Here are lesser known sources, and tips on how to get your hands on them.

UK to bail out biotech
The British government is investing £750 million ($1.1 billion) to bolster the ailing biotech industry and other commercial science and technology sectors.

Opinion: Research redesign
We have met the enemy and he is us: A scientist proposes a redesign of the US biomedical research enterprise


Front Cover

Register for FREE Online Access

  • »Current issue
  • »Best Places to Work and Salary surveys
  • »Daily news and monthly contents emails

Register »

Subscribe to the Magazine

  • »Monthly print issues
  • »Unlimited online access
  • »Special offers on books, apparel, and more

Subscribe »

Library Subscriptions
Recommend to a Librarian

Masthead | Contact | Advertise | Privacy Policy
© 1986-2012 The Scientist